Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Double Helix Bio-technology Development

1995 FOUNDED
M&A STATUS
51-60 EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of market research and consulting services to the healthcare industry. The company offers market research, data analytic, market advisory, planning and consulting, strategy management and pharmaceutical market information services to the healthcare organizations.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Services
Other Industries
Other Commercial Services
Consulting Services (B2B)
Acquirer
McCann Health
Primary Office
  • 88 Baker Street
  • London W1U 6TQ
  • England, United Kingdom

Double Helix Bio-technology Development Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Double Helix Bio-technology Development‘s full profile, request access.

Request full access to PitchBook

Double Helix Bio-technology Development Executive Team (3)

Name Title Board
Seat
Contact
Info
Charlie Buckwell Chief Executive Officer
Jim Goldenberg President

1 Former Executive

You’re viewing 2 of 3 executives. Get the full list »